NCT01273545

PRILIGY Usage Patterns in Selected Populations

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (actual)
• Sponsor: Janssen Research & Development, LLC · Industry
• Sex: Male
• Age: —
• Healthy volunteers: Not accepted

Summary

This study will use electronic health services databases to describe the usage patterns of dapoxetine hydrochloride (PRILIGY) in Germany and Italy with a focus on describing the extent and proportion of patients with characteristics suggestive of the use of PRILIGY within, versus outside of the intended use population.

Detailed description

This study will use anonymized (nameless) patient data from electronic health services databases in Germany and Italy to describe the proportion of PRILIGY (dapoxetine hydrochloride) usage among those patients with characteristics suggestive of the use of PRILIGY within versus outside (eg, those with contraindications) of the intended use (IU) population. This is an observational study; no investigational drug will be administered.

Conditions

• Sexual Dysfunction, Physiological

Interventions

Type	Name	Description
DRUG	PRILIGY (dapoxetine hydrochloride)	The study will observe characteristics of the patients to whom PRILIGY 30-mg and 60-mg tablets are prescribed in Germany by general practitioners and (separately) by urologists, and in Italy by urologists

Timeline

• Start date: 2010-01-01
• Completion: 2012-12-01
• First posted: 2011-01-10
• Last updated: 2014-04-08